Financial, market and economic news

Roche’s (RHHBY) Influenza Drug Gets Positive CHMP Opinion

Roche RHHBY announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of influenza drug Xofluza (baloxavir marboxil).

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy